Opinion|Videos|September 11, 2024
Recommendations and Outlook for Central Precocious Puberty
Experts offer recommendations for supporting central precocious puberty patients in managing the social stigma and challenges associated with their condition.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Can you provide any recommendations on supporting patients navigating stigmas and social hardships associated with CPP?
- Please provide any closing thoughts regarding your clinical experience with the management of CPP and your outlook of the future.
Advertisement
Related to this article
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
In 5.2 million US infants, newborn vitamin K nonreceipt rose to 6.8% by 2025 and was tied to a 47% higher bleeding risk by 6 months.
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
Jessica Nash, MD, IBCLC, shares strategies for assessing breastfeeding, identifying latch problems, and connecting families with lactation resources.
Find out the 4 FDA decisions to watch in November 2026 for pediatric care.
Michael Pistiner, MD, discusses how pediatricians can support food allergy management in schools through accurate diagnosis, emergency plans, and education.
Cenobamate sNDAs target PGTC seizures in patients ≥12 years and pediatric focal seizures; phase 3 PGTC data showed a 71.9% median reduction.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Skipping newborn vitamin K tied to 47% higher infant bleeding risk
2
Contemporary Pediatrics week in review: November 2-6, 2026
3
Study identifies gaps in infant RSV immunization timing
4
Breastfeeding essentials: Assessing latch and milk transfer
5